Close

content

Capsugel Announces Broad Commercial Availability of MASTâ„¢ System

Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions announced the broad commercial availability of its Modular Automated Sampling Technologyâ„¢ (MAST)...

QPSI Announces Acquisition Of Pharmaceutical Packaging Company, International Labs

Quality Packaging Specialists International, LLC (QPSI) has acquired 100% ownership of International Labs, LLC (INL) in an equity exchange transaction. Terms...

GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma

GW Pharmaceuticals plc , a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform. ...

Intarcia Announces FDA Filing Acceptance of NDA for ITCA 650 for the Treatment of Type 2 Diabetes

Intarcia Therapeutics, Inc. announced that the U.S. FDA has accepted for active review its NDA for ITCA 650, an investigational therapy for the treatment...

Envisia therapeutics releases interim Env515 phase 2 data results 

Envisia Therapeutics, a clinical-stage biotechnology company focused on the development of novel extended-release therapies in ophthalmology released an interim analysis of the second cohort...

Arven Pharmaceuticals selects GE Healthcare’s FlexFactory to improve Turkish and regional access to biopharmaceuticals

Arven Pharmaceuticals, a Toksoz Group Company, has selected GE Healthcare’s FlexFactory manufacturing platform to expand production capacity at its facility in Kirklareli, Turkey. ...

MeiraGTx Awarded Target ALS Grant For Its NMD-Based Therapy for ALS

MeiraGTx, a New York and UK based gene therapy company, announced that it has been awarded a grant from Target ALS, a privately funded...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read